Jubilant Life Sciences, 530019, JUBILANT Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,185.46
14.70
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

11,655.48
0.88%
1.64

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.16
9.35
15.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.84
19.91
5.27

PAT CAGR (%)

10 Years
5 Years
3 Years

3.15
-6.37
-0.07

P:E (Median)

8 Years
5 Years
3 Years

17.09
16.97
19.06

P:BV (Average)

8 Years
5 Years
3 Years

1.85
2.34
2.83

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.42
9.48
9.89

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 789.82 826.64 -4.45% 865.12 964.43 -10.30% 859.58 933.83 -7.95% 887.27 734.48 20.80%
Expenses 691.83 745.60 -7.21% 809.13 800.03 1.14% 758.76 742.50 2.19% 804.25 623.12 29.07%
EBITDA 97.99 81.04 20.92% 55.99 164.40 -65.94% 100.82 191.33 -47.31% 83.02 111.36 -25.45%
EBIDTM 12.41% 9.80% 6.47% 17.05% 11.73% 20.49% 9.36% 15.16%
Other Income 5.94 4.41 34.69% 4.83 7.89 -38.78% 4.96 6.05 -18.02% 63.80 21.52 196.47%
Interest 32.95 30.95 6.46% 32.33 32.75 -1.28% 31.60 33.63 -6.04% 34.08 33.48 1.79%
Depreciation 23.66 21.05 12.40% 22.10 20.76 6.45% 21.80 20.52 6.24% 21.53 21.13 1.89%
PBT 47.32 33.45 41.46% 6.39 118.78 -94.62% 52.38 143.23 -63.43% 91.21 78.27 16.53%
Tax 15.06 9.57 57.37% -1.05 32.39 - 15.68 45.35 -65.42% 11.60 21.39 -45.77%
PAT 32.26 23.88 35.09% 7.44 86.39 -91.39% 36.70 97.88 -62.51% 79.61 56.88 39.96%
PATM 4.08% 2.89% 0.86% 8.96% 4.27% 10.48% 8.97% 7.74%
EPS 2.03 1.50 35.33% 0.47 5.42 -91.33% 2.30 6.14 -62.54% 5.00 3.57 40.06%

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 2,181.86 2,078.65 4.97% 2,385.58 2,251.96 5.93% 2,377.10 2,067.76 14.96% 2,269.49 1,642.04 38.21%
Expenses 1,747.26 1,641.05 6.47% 2,027.61 1,794.09 13.02% 1,883.84 1,650.92 14.11% 1,819.31 1,335.98 36.18%
EBITDA 434.60 437.60 -0.69% 357.97 457.87 -21.82% 493.26 416.84 18.33% 450.18 306.06 47.09%
EBIDTM 19.92% 21.05% 15.01% 20.33% 20.75% 20.16% 19.84% 18.64%
Other Income 9.70 9.47 2.43% -6.58 22.91 - 29.02 3.22 801.24% 3.83 7.09 -45.98%
Interest 72.58 72.70 -0.17% 61.59 72.48 -15.02% 68.27 77.06 -11.41% 62.72 66.01 -4.98%
Depreciation 102.69 88.00 16.69% 95.02 181.74 -47.72% 98.40 81.82 20.26% 89.48 79.01 13.25%
PBT 269.03 286.37 -6.06% -39.98 226.56 - 355.61 261.18 36.16% 301.81 168.13 79.51%
Tax 84.05 86.00 -2.27% 60.67 74.16 -18.19% 88.09 48.34 82.23% 92.04 42.66 115.75%
PAT 184.98 200.37 -7.68% -100.65 152.40 - 267.52 212.84 25.69% 209.77 125.47 67.19%
PATM 8.48% 9.64% -4.22% 6.77% 11.25% 10.29% 9.24% 7.64%
EPS 11.61 13.00 -10.69% -6.23 9.94 - 16.74 13.64 22.73% 13.51 8.24 63.96%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 3,401.79 3,438.61 3,306.32 2,491.22 2,656.15 3,176.30 3,672.79 3,146.30 2,641.07 2,208.48 2,456.06 Net Sales Growth -1.66% 4.00% 32.72% -6.21% -16.38% -13.52% 16.73% 19.13% 19.59% -10.08% Cost Of Goods Sold 1,984.71 2,052.81 1,771.11 1,310.23 1,453.03 1,935.90 1,982.26 1,698.14 1,397.72 1,094.63 1,211.48 Gross Profit 1,417.08 1,385.80 1,535.21 1,180.99 1,203.13 1,240.41 1,690.53 1,448.17 1,243.34 1,113.85 1,244.58 GP Margin 41.66% 40.30% 46.43% 47.41% 45.30% 39.05% 46.03% 46.03% 47.08% 50.44% 50.67% Total Expenditure 3,063.97 3,117.74 2,767.08 2,173.21 2,343.86 2,893.94 3,083.89 2,655.61 2,221.15 1,760.16 1,945.18 Power & Fuel Cost - 358.28 339.80 268.18 298.40 328.83 360.17 336.09 271.54 206.65 199.46 % Of Sales - 10.42% 10.28% 10.77% 11.23% 10.35% 9.81% 10.68% 10.28% 9.36% 8.12% Employee Cost - 265.71 264.42 226.31 216.18 240.83 298.23 249.02 207.23 172.81 165.95 % Of Sales - 7.73% 8.00% 9.08% 8.14% 7.58% 8.12% 7.91% 7.85% 7.82% 6.76% Manufacturing Exp. - 258.31 228.40 206.97 214.72 243.68 257.18 224.90 185.26 145.44 173.09 % Of Sales - 7.51% 6.91% 8.31% 8.08% 7.67% 7.00% 7.15% 7.01% 6.59% 7.05% General & Admin Exp. - 77.63 74.91 68.32 57.32 72.55 104.14 85.17 79.95 72.30 79.24 % Of Sales - 2.26% 2.27% 2.74% 2.16% 2.28% 2.84% 2.71% 3.03% 3.27% 3.23% Selling & Distn. Exp. - 56.30 67.72 58.18 50.59 59.06 68.71 53.13 59.50 54.24 86.04 % Of Sales - 1.64% 2.05% 2.34% 1.90% 1.86% 1.87% 1.69% 2.25% 2.46% 3.50% Miscellaneous Exp. - 48.71 20.72 35.03 53.63 13.10 13.20 9.18 19.95 14.09 86.04 % Of Sales - 1.42% 0.63% 1.41% 2.02% 0.41% 0.36% 0.29% 0.76% 0.64% 1.22% EBITDA 337.82 320.87 539.24 318.01 312.29 282.36 588.90 490.69 419.92 448.32 510.88 EBITDA Margin 9.93% 9.33% 16.31% 12.77% 11.76% 8.89% 16.03% 15.60% 15.90% 20.30% 20.80% Other Income 79.53 78.00 46.21 51.90 61.74 106.42 29.88 34.97 39.34 26.72 128.39 Interest 130.96 128.96 135.17 174.25 200.66 233.29 284.80 262.57 193.12 70.63 114.89 Depreciation 89.09 86.48 82.59 81.13 86.98 107.41 175.29 152.17 132.00 99.91 65.11 PBT 197.30 183.43 367.69 114.52 86.39 48.08 158.71 110.92 134.14 304.50 459.27 Tax 41.29 35.80 104.25 35.33 13.39 41.19 -68.98 30.51 34.97 20.32 96.17 Tax Rate 20.93% 19.52% 28.35% 30.85% 15.50% 16.72% 101.22% -238.17% -76.12% 6.77% 20.94% PAT 156.01 147.63 263.44 79.19 73.00 205.11 0.82 -43.32 -80.92 279.63 363.10 PAT before Minority Interest 156.01 147.63 263.44 79.19 73.00 205.11 0.82 -43.32 -80.92 279.63 363.10 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.59% 4.29% 7.97% 3.18% 2.75% 6.46% 0.02% -1.38% -3.06% 12.66% 14.78% PAT Growth -41.13% -43.96% 232.67% 8.48% -64.41% 24,913.41% - - - -22.99% Unadjusted EPS 9.80 9.27 16.54 4.97 4.58 12.88 0.05 -2.72 -5.08 17.56 24.60

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 9,214.03 9,110.82 7,517.84 5,861.43 5,749.13 5,826.25 5,803.36 5,165.95 4,303.13 3,445.62 3,791.13 Net Sales Growth 14.60% 21.19% 28.26% 1.95% -1.32% 0.39% 12.34% 20.05% 24.89% -9.11% Cost Of Goods Sold 3,480.75 3,521.84 2,862.51 2,002.74 2,116.20 2,663.02 2,438.46 2,062.85 1,618.87 1,339.68 1,471.11 Gross Profit 5,733.28 5,588.98 4,655.33 3,858.69 3,632.94 3,163.23 3,364.90 3,103.10 2,684.26 2,105.95 2,320.02 GP Margin 62.22% 61.34% 61.92% 65.83% 63.19% 54.29% 57.98% 60.07% 62.38% 61.12% 61.20% Total Expenditure 7,478.02 7,371.81 5,999.45 4,516.14 4,502.19 5,124.71 4,782.37 4,097.81 3,412.94 2,880.76 3,111.07 Power & Fuel Cost - 466.38 424.91 333.66 366.71 393.04 389.74 356.73 286.89 224.04 220.03 % Of Sales - 5.12% 5.65% 5.69% 6.38% 6.75% 6.72% 6.91% 6.67% 6.50% 5.80% Employee Cost - 1,925.96 1,555.88 1,230.93 1,125.09 1,090.28 1,105.17 962.58 836.36 718.54 735.21 % Of Sales - 21.14% 20.70% 21.00% 19.57% 18.71% 19.04% 18.63% 19.44% 20.85% 19.39% Manufacturing Exp. - 552.26 485.98 428.84 436.46 432.40 405.14 360.48 329.75 284.66 315.90 % Of Sales - 6.06% 6.46% 7.32% 7.59% 7.42% 6.98% 6.98% 7.66% 8.26% 8.33% General & Admin Exp. - 540.75 365.54 280.98 256.23 302.28 264.23 208.35 200.72 195.72 196.68 % Of Sales - 5.94% 4.86% 4.79% 4.46% 5.19% 4.55% 4.03% 4.66% 5.68% 5.19% Selling & Distn. Exp. - 267.70 247.85 185.79 135.54 203.98 160.04 123.28 111.85 90.92 125.97 % Of Sales - 2.94% 3.30% 3.17% 2.36% 3.50% 2.76% 2.39% 2.60% 2.64% 3.32% Miscellaneous Exp. - 96.92 56.78 53.20 65.96 39.72 19.59 23.53 28.50 27.21 125.97 % Of Sales - 1.06% 0.76% 0.91% 1.15% 0.68% 0.34% 0.46% 0.66% 0.79% 1.22% EBITDA 1,736.01 1,739.01 1,518.39 1,345.29 1,246.94 701.54 1,020.99 1,068.14 890.19 564.86 680.06 EBITDA Margin 18.84% 19.09% 20.20% 22.95% 21.69% 12.04% 17.59% 20.68% 20.69% 16.39% 17.94% Other Income 35.97 35.74 40.03 24.86 13.37 42.45 19.06 29.87 31.48 17.24 118.09 Interest 265.16 219.81 284.28 341.11 371.35 367.61 337.11 310.93 238.23 119.99 155.57 Depreciation 385.59 370.90 415.05 291.40 346.74 287.95 281.17 253.79 220.65 180.10 124.68 PBT 886.47 1,184.04 859.08 737.64 542.22 88.43 421.78 533.29 462.79 282.02 517.90 Tax 324.85 326.80 224.66 163.02 155.40 80.48 69.64 152.36 68.41 13.37 95.94 Tax Rate 36.65% 36.16% 26.15% 22.10% 28.66% 199.55% 33.60% 44.66% 59.95% 5.56% 18.52% PAT 561.62 574.46 642.81 575.66 391.83 -57.76 109.04 152.73 14.56 229.72 421.46 PAT before Minority Interest 556.94 577.01 634.42 574.63 386.82 -40.16 137.64 188.78 45.69 227.23 421.95 Minority Interest -4.68 -2.55 8.39 1.03 5.01 -17.60 -28.60 -36.05 -31.13 2.49 -0.49 PAT Margin 6.10% 6.31% 8.55% 9.82% 6.82% -0.99% 1.88% 2.96% 0.34% 6.67% 11.12% PAT Growth -18.73% -10.63% 11.66% 46.92% - - -28.61% 948.97% -93.66% -45.49% Unadjusted EPS 35.63 36.86 41.25 36.93 25.10 -3.63 6.85 9.59 0.91 14.42 28.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 2,340.31 2,249.38 2,042.81 2,013.73 1,944.96 1,732.75 1,843.59 1,917.10 2,140.59 2,172.85 Share Capital 15.93 15.93 15.93 15.93 15.93 15.45 15.93 15.93 15.93 15.88 Total Reserves 2,324.33 2,233.29 2,026.39 1,997.80 1,929.04 1,717.31 1,827.66 1,901.17 2,124.66 2,156.97 Non-Current Liabilities 1,225.58 1,136.68 1,428.31 1,136.80 1,988.09 1,535.29 2,543.81 2,790.51 2,459.84 2,217.25 Secured Loans 802.83 725.14 1,047.78 1,093.32 1,636.18 1,039.46 2,008.38 2,422.21 1,839.06 1,001.28 Unsecured Loans 336.74 334.24 339.24 21.51 102.89 101.59 42.87 0.00 400.00 1,010.99 Long Term Provisions 61.95 57.37 50.69 45.44 97.05 210.41 227.35 156.88 30.88 0.00 Current Liabilities 1,297.73 1,238.48 910.67 1,155.23 1,307.78 3,382.48 2,104.30 1,466.57 1,684.66 966.98 Trade Payables 596.05 749.18 486.91 364.49 507.57 599.25 515.22 706.70 415.89 492.10 Other Current Liabilities 214.28 270.24 224.33 316.73 388.02 1,468.25 465.30 186.79 143.22 27.46 Short Term Borrowings 462.71 190.64 177.07 453.94 340.43 1,097.13 1,042.70 484.73 741.21 0.00 Short Term Provisions 24.70 28.42 22.36 20.07 71.75 217.86 81.08 88.35 384.33 447.43 Total Liabilities 4,863.62 4,624.54 4,381.79 4,305.76 5,240.83 6,650.52 6,491.70 6,174.18 6,285.09 5,357.08 Net Block 1,491.35 1,437.81 1,421.15 1,415.24 1,445.93 2,151.14 2,185.48 1,840.07 1,538.51 1,459.25 Gross Block 1,822.01 1,684.84 1,587.18 1,501.57 2,302.83 3,243.34 3,104.96 2,613.31 2,181.11 2,050.60 Accumulated Depreciation 330.66 247.03 166.03 86.33 856.90 1,092.20 919.47 773.24 642.60 591.35 Non Current Assets 3,582.46 3,298.65 3,237.48 3,238.16 3,586.53 4,701.50 4,721.40 4,660.64 4,213.06 3,414.42 Capital Work in Progress 283.82 115.32 65.40 35.68 20.02 241.94 213.36 418.96 417.01 272.19 Non Current Investment 1,763.89 1,706.30 1,699.94 1,701.90 1,766.26 2,005.69 1,978.51 1,938.02 1,852.31 1,682.98 Long Term Loans & Adv. 18.02 12.27 21.80 55.41 310.60 267.34 343.84 463.22 405.23 0.00 Other Non Current Assets 25.38 26.95 29.19 29.92 43.72 35.39 0.22 0.37 0.00 0.00 Current Assets 1,281.17 1,325.89 1,144.31 1,067.60 1,654.31 1,949.02 1,770.30 1,513.54 2,072.03 1,942.66 Current Investments 0.00 0.00 9.70 7.35 0.00 0.38 0.00 21.70 11.75 186.22 Inventories 491.94 585.58 454.43 475.26 515.86 733.52 612.48 593.33 404.70 424.71 Sundry Debtors 480.52 493.66 385.67 341.30 318.76 529.60 393.25 403.82 334.52 307.31 Cash & Bank 34.74 37.51 76.66 41.05 136.74 178.71 255.88 202.83 985.26 434.22 Other Current Assets 273.96 164.36 184.96 189.22 682.95 506.82 508.68 291.86 335.80 590.20 Short Term Loans & Adv. 23.83 44.78 32.90 13.42 647.53 446.31 375.70 221.28 245.08 564.21 Net Current Assets -16.57 87.41 233.63 -87.63 346.53 -1,433.46 -334.00 46.96 387.38 975.68 Total Assets 4,863.63 4,624.54 4,381.79 4,305.76 5,240.84 6,650.52 6,491.70 6,174.18 6,285.09 5,357.08

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 4,808.92 4,086.53 3,436.04 2,966.26 2,453.52 2,626.51 2,476.12 2,257.03 2,172.27 2,201.34 Share Capital 15.93 15.58 15.57 15.54 15.93 15.45 15.93 15.93 15.93 15.88 Total Reserves 4,792.94 4,070.78 3,419.98 2,950.72 2,437.59 2,611.07 2,460.19 2,241.10 2,156.34 2,185.46 Non-Current Liabilities 4,420.21 3,417.47 3,826.06 3,347.13 4,036.15 2,184.95 3,004.85 3,224.12 3,048.25 3,365.15 Secured Loans 811.65 1,109.17 1,581.96 2,620.41 3,316.29 1,716.67 1,708.74 2,839.47 2,435.91 2,160.79 Unsecured Loans 3,431.24 1,938.64 1,923.07 392.79 375.00 0.22 760.06 0.45 400.61 1,011.94 Long Term Provisions 114.35 107.08 80.69 70.31 67.04 219.53 237.96 169.70 39.87 0.00 Current Liabilities 2,089.73 2,004.69 1,684.04 2,464.44 2,129.16 3,894.41 2,778.35 2,212.79 2,269.67 1,220.11 Trade Payables 1,020.13 1,136.16 749.49 612.12 721.19 718.14 647.13 836.98 517.43 688.83 Other Current Liabilities 473.57 505.87 572.70 951.43 793.31 1,731.20 898.00 499.55 465.94 64.70 Short Term Borrowings 499.71 244.85 255.60 748.97 517.17 1,187.83 1,131.39 767.07 883.03 0.00 Short Term Provisions 96.31 117.81 106.24 151.93 97.49 257.25 101.84 109.18 403.28 466.59 Total Liabilities 11,318.96 9,457.17 8,898.75 8,739.70 8,618.83 8,863.81 8,370.86 7,762.89 7,532.00 6,824.52 Net Block 5,648.38 5,400.55 5,106.73 5,104.42 4,911.33 5,098.78 4,967.46 4,460.18 3,991.05 3,818.89 Gross Block 6,905.50 6,288.86 5,672.38 5,390.82 7,362.10 7,330.63 6,870.15 6,084.09 5,163.28 4,845.26 Accumulated Depreciation 1,257.12 888.31 565.66 286.40 2,450.76 2,231.85 1,902.69 1,623.92 1,172.22 1,026.38 Non Current Assets 6,734.16 6,267.41 5,950.63 5,864.37 5,904.29 5,935.78 5,809.80 5,465.57 4,940.25 4,357.21 Capital Work in Progress 901.43 670.97 683.78 611.32 596.60 472.39 436.89 685.55 666.71 505.63 Non Current Investment 115.11 123.52 102.71 85.43 39.50 33.99 25.61 19.20 32.75 32.70 Long Term Loans & Adv. 68.59 71.79 56.32 62.67 327.17 328.42 379.47 299.86 249.18 0.00 Other Non Current Assets 0.66 0.58 1.08 0.53 29.68 2.21 0.37 0.79 0.55 0.00 Current Assets 4,584.80 3,189.76 2,948.12 2,875.32 2,714.54 2,928.03 2,561.06 2,297.32 2,591.75 2,455.22 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 223.71 Inventories 1,417.39 1,391.39 1,220.40 1,203.10 1,235.33 1,341.42 1,116.18 1,020.22 691.28 690.95 Sundry Debtors 1,271.55 1,130.76 1,005.30 950.50 819.27 805.87 708.54 652.69 520.45 518.61 Cash & Bank 1,370.41 248.79 459.63 344.58 394.34 479.53 356.05 266.82 1,045.14 503.67 Other Current Assets 525.44 373.06 225.73 244.07 265.59 301.21 380.29 357.59 334.88 518.27 Short Term Loans & Adv. 39.80 45.75 37.06 133.06 144.56 136.04 182.01 256.70 217.50 498.14 Net Current Assets 2,495.07 1,185.06 1,264.08 410.88 585.38 -966.38 -217.29 84.53 322.08 1,235.11 Total Assets 11,318.96 9,457.17 8,898.75 8,739.69 8,618.83 8,863.81 8,370.86 7,762.89 7,532.00 6,824.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 181.74 557.85 419.15 164.30 285.55 548.68 827.22 405.56 239.66 601.33 PBT 183.43 367.69 114.52 86.39 246.30 -68.16 -12.81 -45.95 299.95 459.27 Adjustment 159.26 206.69 230.45 259.62 59.49 606.08 533.09 476.75 144.79 72.46 Changes in Working Capital -112.03 41.63 79.56 -168.06 17.57 11.79 323.77 1.39 -122.92 127.21 Cash after chg. in Working capital 230.66 616.02 424.53 177.94 323.36 549.72 844.06 432.19 321.82 658.93 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.48 Tax Paid -48.92 -58.17 -5.38 -13.65 -37.81 -1.04 -16.84 -26.63 -82.18 -58.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -284.79 -126.93 -43.06 521.70 1,319.35 -193.78 -399.45 -501.52 -424.69 -342.01 Net Fixed Assets -305.67 -147.58 -115.33 785.60 1,162.43 -166.96 -286.05 -434.15 -275.33 -128.63 Net Investments -57.59 3.34 -0.39 57.01 239.81 -27.56 -18.79 -95.66 5.14 -159.67 Others 78.47 17.31 72.66 -320.91 -82.89 0.74 -94.61 28.29 -154.50 -53.71 Cash from Financing Activity 85.28 -470.44 -338.40 -784.44 -1,646.65 -360.79 -445.73 -686.39 885.55 -102.37 Net Cash Inflow / Outflow -17.77 -39.52 37.69 -98.44 -41.75 -5.90 -17.96 -782.36 700.52 156.95 Opening Cash & Equivalents 36.47 75.99 38.29 136.74 178.49 184.38 202.34 984.70 433.75 278.93 Closing Cash & Equivalent 18.70 36.47 75.99 38.29 136.74 178.49 184.38 202.34 984.70 435.88

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 1,121.51 1,303.20 1,268.49 1,098.89 783.26 772.27 969.90 707.17 389.75 709.61 PBT 903.81 859.08 737.64 542.22 40.32 207.28 341.14 114.11 240.59 517.90 Adjustment 861.53 687.81 637.90 737.89 725.84 756.60 752.36 795.44 318.42 189.22 Changes in Working Capital -300.53 14.15 36.88 -133.16 96.40 -110.70 -4.04 -136.91 -84.14 62.58 Cash after chg. in Working capital 1,464.82 1,561.04 1,412.42 1,146.96 862.57 853.18 1,089.46 772.64 474.88 769.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -343.31 -257.84 -143.94 -48.07 -79.31 -80.91 -119.56 -65.47 -85.14 -60.57 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,011.84 -617.70 -450.39 -312.53 -343.33 -174.42 -499.72 -594.31 -352.15 -279.75 Net Fixed Assets -305.67 -147.58 -115.33 785.60 1,162.43 -166.96 -286.05 -434.15 -275.33 -128.63 Net Investments -57.59 3.34 -0.39 57.01 239.81 -27.56 -18.79 -95.66 5.14 -159.67 Others -648.58 -473.46 -334.67 -1,155.14 -1,745.57 20.10 -194.88 -64.50 -81.96 8.55 Cash from Financing Activity 657.43 -901.13 -685.87 -842.75 -502.69 -414.41 -449.76 -888.82 608.21 -298.02 Net Cash Inflow / Outflow 767.10 -215.63 132.22 -56.38 -62.76 183.44 20.41 -775.95 645.81 131.84 Opening Cash & Equivalents 244.18 456.44 339.27 391.64 473.49 279.65 263.08 1,041.15 498.27 381.66 Closing Cash & Equivalent 1,005.40 244.18 456.44 339.27 391.63 473.49 279.65 263.08 1,041.15 505.34

Financial Ratios

Consolidated /

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 146.93 141.21 128.22 126.43 122.11 112.20 115.75 120.36 134.39 136.85 ROA 3.11% 5.85% 1.82% 1.53% 3.45% 0.01% -0.68% -1.30% 4.80% 7.03% ROE 6.43% 12.28% 3.90% 3.69% 11.15% 0.05% -2.30% -3.99% 12.97% 19.78% ROCE 8.10% 13.57% 7.64% 7.13% 10.35% 4.27% 5.02% 2.95% 7.96% 13.99% Fixed Asset Turnover 1.96 2.04 1.70 1.47 1.20 1.20 1.14 1.14 1.08 1.28 Receivable days 51.70 48.00 50.58 43.16 46.50 44.21 44.53 49.30 51.26 47.68 Inventory Days 57.19 56.78 64.69 64.81 68.48 64.48 67.37 66.64 66.24 54.50 Payable days 80.49 81.70 70.96 68.13 68.44 64.82 55.20 40.44 50.99 52.56 Cash Conversion Cycle 28.41 23.08 44.31 39.84 46.55 43.87 56.70 75.50 66.50 49.61 Total Debt/Equity 0.73 0.63 0.83 0.90 1.17 1.91 1.77 1.53 1.40 0.93 Interest Cover 2.42 3.72 1.66 1.43 2.06 0.76 0.95 0.76 5.25 5.00

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 301.93 262.33 220.61 190.90 154.04 170.07 155.46 141.70 136.38 137.88 ROA 5.55% 6.91% 6.52% 4.46% -0.46% 1.60% 2.34% 0.60% 3.17% 6.21% ROE 12.97% 16.87% 17.95% 14.27% -1.58% 5.39% 7.98% 2.06% 10.42% 24.42% ROCE 13.06% 15.21% 14.44% 12.42% 5.72% 7.92% 10.19% 5.79% 6.29% 12.74% Fixed Asset Turnover 1.38 1.26 1.09 0.92 0.81 0.84 0.82 0.78 0.70 0.82 Receivable days 48.12 51.58 59.43 54.81 49.56 46.53 47.00 48.71 53.83 48.18 Inventory Days 56.26 63.07 73.64 75.51 78.58 75.51 73.76 71.07 71.61 60.59 Payable days 55.42 56.86 54.84 53.44 52.17 51.42 45.33 38.70 50.95 58.42 Cash Conversion Cycle 48.96 57.79 78.23 76.88 75.98 70.61 75.42 81.08 74.50 50.34 Total Debt/Equity 1.01 0.85 1.18 1.51 1.95 1.67 1.71 1.69 1.81 1.45 Interest Cover 5.11 4.02 3.16 2.46 1.11 1.61 2.10 1.48 3.01 4.33

Top Investors:

east bridge capital master fund limited

government pension fund global

motilal oswal mutual funds

rakesh radheshyam jhunjhunwala

lazard emerging markets small cap equity trust

morgan stanley asia (singapore) pte.

dsp top 100 equity fund

iepf

Annual Reports:

News Update:

Jubilant Life Sciences issues CPs worth Rs 40 crore
5th Aug 2019, 10:23 AM

The coupon / interest offered is 6.75% per annum
Read More
Jubilant Life Sciences to evaluate creation of focused entities for businesses
27th Jul 2019, 09:29 AM

The company will enable strategic growth for businesses with optimal capital structure
Read More
Jubilant Life Sciences reports 7% fall in Q1 consolidated net profit
26th Jul 2019, 15:13 PM

Total consolidated income of the company increased by 4.95% at Rs 2,191.56 crore for Q1FY20
Read More
Jubilant LifeScience - Quarterly Results
26th Jul 2019, 14:56 PM

Read More
Jubilant Life Sciences increases price of Vitamin B3
16th Jul 2019, 09:07 AM

The company has increased the prices with immediate effect, for non-contract customers and wherever existing contracts permit
Read More
Jubilant Life Sciences raises Rs 40 crore via CPs
26th Jun 2019, 09:06 AM

The tenure of the instrument is 36 days and maturity date is July 31, 2019
Read More

Jubilant Life Sciences Ltd.

Chemicals

BSE: 530019 | NSE: JUBILANT

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Jubilant Life Sciences Ltd.

Chemicals

BSE: 530019 | NSE: JUBILANT

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: